• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在LysM+髓样细胞中删除自分泌运动因子会损害转移性黑色素瘤模型中的先天性肿瘤免疫。

Deleting autotaxin in LysM+ myeloid cells impairs innate tumor immunity in models of metastatic melanoma.

作者信息

Dacheux Mélanie A, Norman Derek D, Shin Yoojin, Tigyi Gábor J, Lee Sue Chin

机构信息

Department of Physiology, University of Tennessee Health Science Center Memphis, 3N. Dunlap Street, Memphis, TN 38163, USA.

出版信息

iScience. 2024 Sep 17;27(10):110971. doi: 10.1016/j.isci.2024.110971. eCollection 2024 Oct 18.

DOI:10.1016/j.isci.2024.110971
PMID:39398245
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11467674/
Abstract

Autotaxin (ATX) is a lysophospholipase D that generates lysophosphatidic acid (LPA) and regulates cancer metastasis, therapeutic resistance, and tumor immunity. We found that myeloid cells in human melanoma biopsies abundantly express ATX and investigated its role in modulating innate tumor immunity using two models of melanoma metastasis-spontaneous and experimental. Targeted knockout of ATX in LysM+ myeloid cells in mice (LysM-KO) reduced both spontaneous and experimental B16-F10 melanoma metastases by ≥ 50%. Immunoprofiling revealed differences in M2-like alveolar macrophages, neutrophils and regulatory T cells in the metastatic lungs of LysM-WT versus LysM-KO that are model-dependent. These differences extend systemically, with LysM-KO mice bearing experimental metastasis having fewer neutrophils in the spleen than LysM-WT mice. Our results show that (1) LysM+ myeloid cells are an important source of ATX/LPA that promote melanoma metastasis by altering innate tumor immunity, and (2) intratumor and systemic immune profiles vary dynamically during disease progression and are model-dependent.

摘要

自分泌运动因子(ATX)是一种溶血磷脂酶D,可生成溶血磷脂酸(LPA),并调节癌症转移、治疗抗性和肿瘤免疫。我们发现,人类黑色素瘤活检组织中的髓样细胞大量表达ATX,并使用两种黑色素瘤转移模型——自发转移模型和实验转移模型,研究了其在调节先天性肿瘤免疫中的作用。在小鼠的LysM+髓样细胞中靶向敲除ATX(LysM-KO)可使自发和实验性B16-F10黑色素瘤转移减少≥50%。免疫分析显示,LysM-WT与LysM-KO转移性肺组织中M2样肺泡巨噬细胞、中性粒细胞和调节性T细胞存在差异,且这些差异取决于模型。这些差异具有全身性,携带实验性转移瘤的LysM-KO小鼠脾脏中的中性粒细胞比LysM-WT小鼠少。我们的结果表明:(1)LysM+髓样细胞是ATX/LPA的重要来源,通过改变先天性肿瘤免疫促进黑色素瘤转移;(2)在疾病进展过程中,肿瘤内和全身免疫谱会动态变化,且取决于模型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9555/11467674/5b74012f6176/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9555/11467674/b6a67fdcd33d/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9555/11467674/19f0a7cc5a3d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9555/11467674/a3f4552f736f/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9555/11467674/02c09541f283/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9555/11467674/9a584f726796/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9555/11467674/bd54a86e09b5/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9555/11467674/5b74012f6176/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9555/11467674/b6a67fdcd33d/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9555/11467674/19f0a7cc5a3d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9555/11467674/a3f4552f736f/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9555/11467674/02c09541f283/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9555/11467674/9a584f726796/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9555/11467674/bd54a86e09b5/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9555/11467674/5b74012f6176/gr6.jpg

相似文献

1
Deleting autotaxin in LysM+ myeloid cells impairs innate tumor immunity in models of metastatic melanoma.在LysM+髓样细胞中删除自分泌运动因子会损害转移性黑色素瘤模型中的先天性肿瘤免疫。
iScience. 2024 Sep 17;27(10):110971. doi: 10.1016/j.isci.2024.110971. eCollection 2024 Oct 18.
2
Prometastatic Effect of ATX Derived from Alveolar Type II Pneumocytes and B16-F10 Melanoma Cells.源自II型肺泡上皮细胞和B16-F10黑色素瘤细胞的自分泌运动因子的促转移作用。
Cancers (Basel). 2022 Mar 21;14(6):1586. doi: 10.3390/cancers14061586.
3
Autotaxin and LPA1 and LPA5 receptors exert disparate functions in tumor cells versus the host tissue microenvironment in melanoma invasion and metastasis.自分泌运动因子以及溶血磷脂酸1和溶血磷脂酸5受体在黑色素瘤侵袭和转移过程中,在肿瘤细胞与宿主组织微环境中发挥不同的功能。
Mol Cancer Res. 2015 Jan;13(1):174-85. doi: 10.1158/1541-7786.MCR-14-0263. Epub 2014 Aug 26.
4
Autotaxin impedes anti-tumor immunity by suppressing chemotaxis and tumor infiltration of CD8 T cells.自分泌酶通过抑制趋化作用和 CD8 T 细胞的肿瘤浸润来阻碍抗肿瘤免疫。
Cell Rep. 2021 Nov 16;37(7):110013. doi: 10.1016/j.celrep.2021.110013.
5
Cancer cell expression of autotaxin controls bone metastasis formation in mouse through lysophosphatidic acid-dependent activation of osteoclasts.癌 细 胞 表 达 的 自 动 血 栓 溶 酶 原 控 制 了 骨 转 移 在 小 鼠 中 的 形 成,通 过 磷 脂 酸 依 赖 性 激 活 破 骨 细 胞。
PLoS One. 2010 Mar 17;5(3):e9741. doi: 10.1371/journal.pone.0009741.
6
Uncovering unique roles of LPA receptors in the tumor microenvironment.揭示溶血磷脂酸(LPA)受体在肿瘤微环境中的独特作用。
Receptors Clin Investig. 2015;2(1). doi: 10.14800/rci.440.
7
Suppression of metastasis of intravenously-inoculated B16/F10 melanoma cells by the novel ginseng-derived ingredient, gintonin: involvement of autotaxin inhibition.新型人参成分金雀异黄素抑制静脉接种 B16/F10 黑色素瘤细胞的转移:涉及自分泌酶抑制。
Int J Oncol. 2013 Jan;42(1):317-26. doi: 10.3892/ijo.2012.1709. Epub 2012 Nov 20.
8
House dust mite-driven neutrophilic airway inflammation in mice with TNFAIP3-deficient myeloid cells is IL-17-independent.髓系细胞中缺失 TNFAIP3 的小鼠,由屋尘螨引起的中性粒细胞性气道炎症与白细胞介素-17 无关。
Clin Exp Allergy. 2018 Dec;48(12):1705-1714. doi: 10.1111/cea.13262. Epub 2018 Sep 27.
9
Benzyl and naphthalene methylphosphonic acid inhibitors of autotaxin with anti-invasive and anti-metastatic activity.苄基和萘基甲基膦酸衍生物作为自分泌运动因子抑制剂的抗肿瘤侵袭和转移活性。
ChemMedChem. 2011 May 2;6(5):922-35. doi: 10.1002/cmdc.201000425. Epub 2011 Apr 4.
10
Roles of Autotaxin/Autotaxin-Lysophosphatidic Acid Axis in the Initiation and Progression of Liver Cancer.自分泌运动因子/自分泌运动因子-溶血磷脂酸轴在肝癌发生发展中的作用
Front Oncol. 2022 Jun 13;12:922945. doi: 10.3389/fonc.2022.922945. eCollection 2022.

本文引用的文献

1
Autotaxin-lysolipid signaling suppresses a CCL11-eosinophil axis to promote pancreatic cancer progression.自分泌酶-溶血磷脂信号抑制 CCL11-嗜酸性粒细胞轴促进胰腺癌进展。
Nat Cancer. 2024 Feb;5(2):283-298. doi: 10.1038/s43018-023-00703-y. Epub 2024 Jan 9.
2
Autotaxin suppresses cytotoxic T cells via LPAR5 to promote anti-PD-1 resistance in non-small cell lung cancer.自分泌酶通过 LPAR5 抑制细胞毒性 T 细胞,从而促进非小细胞肺癌对 PD-1 抑制剂的耐药性。
J Clin Invest. 2023 Sep 1;133(17):e163128. doi: 10.1172/JCI163128.
3
Experimental and spontaneous metastasis assays can result in divergence in clonal architecture.
实验性和自发性转移测定可能导致克隆结构的分歧。
Commun Biol. 2023 Aug 7;6(1):821. doi: 10.1038/s42003-023-05167-5.
4
Sex-Biased T-cell Exhaustion Drives Differential Immune Responses in Glioblastoma.性别偏倚的 T 细胞耗竭导致胶质母细胞瘤的免疫反应存在差异。
Cancer Discov. 2023 Sep 6;13(9):2090-2105. doi: 10.1158/2159-8290.CD-22-0869.
5
Autotaxin Inhibition with IOA-289 Decreases Breast Tumor Growth in Mice Whereas Knockout of Autotaxin in Adipocytes Does Not.用IOA - 289抑制自分泌运动因子可减少小鼠乳腺肿瘤生长,而脂肪细胞中自分泌运动因子基因敲除则无此效果。
Cancers (Basel). 2023 May 26;15(11):2937. doi: 10.3390/cancers15112937.
6
Exosome-associated lysophosphatidic acid signaling contributes to cancer pain.外泌体相关溶血磷脂酸信号通路促进癌症痛。
Pain. 2023 Dec 1;164(12):2684-2695. doi: 10.1097/j.pain.0000000000002967. Epub 2023 Jun 6.
7
Lysophosphatidic acid modulates CD8 T cell immunosurveillance and metabolism to impair anti-tumor immunity.溶血磷脂酸调节 CD8 T 细胞免疫监视和代谢,从而损害抗肿瘤免疫。
Nat Commun. 2023 Jun 3;14(1):3214. doi: 10.1038/s41467-023-38933-4.
8
Characterization and translational development of IOA-289, a novel autotaxin inhibitor for the treatment of solid tumors.IOA-289的特性与转化研究进展,一种用于治疗实体瘤的新型自分泌运动因子抑制剂
Immunooncol Technol. 2023 Apr 8;18:100384. doi: 10.1016/j.iotech.2023.100384. eCollection 2023 Jun.
9
Role of Annexin A1 Secreted by Neutrophils in Melanoma Metastasis.中性粒细胞分泌的膜联蛋白 A1 在黑色素瘤转移中的作用。
Cells. 2023 Jan 27;12(3):425. doi: 10.3390/cells12030425.
10
Emerging strategies in targeting tumor-resident myeloid cells for cancer immunotherapy.针对肿瘤驻留髓系细胞的癌症免疫治疗的新兴策略。
J Hematol Oncol. 2022 Aug 28;15(1):118. doi: 10.1186/s13045-022-01335-y.